Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. [electronic resource]
Producer: 19920113Description: 1797-805 p. digitalISSN:- 0027-8874
- Adult
- Aged
- Agranulocytosis -- chemically induced
- Alkaloids -- adverse effects
- Antineoplastic Agents, Phytogenic -- adverse effects
- Breast Neoplasms -- drug therapy
- Doxorubicin -- therapeutic use
- Drug Evaluation
- Female
- Heart Diseases -- chemically induced
- Humans
- Methotrexate -- therapeutic use
- Middle Aged
- Muscular Diseases -- chemically induced
- Paclitaxel
- Pain -- chemically induced
- Peripheral Nervous System Diseases -- chemically induced
- Remission Induction
- Soft Tissue Neoplasms -- drug therapy
- Thrombocytopenia -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.